PT  - JOURNAL ARTICLE
AU  - Horn, Abigail L.
AU  - Jiang, Lai
AU  - Washburn, Faith
AU  - Hvitfeldt, Emil
AU  - de la Haye, Kayla
AU  - Nicholas, William
AU  - Simon, Paul
AU  - Pentz, Maryann
AU  - Cozen, Wendy
AU  - Sood, Neeraj
AU  - Conti, David V.
TI  - Estimation of COVID-19 risk-stratified epidemiological parameters and policy implications for Los Angeles County through an integrated risk and stochastic epidemiological model
AID  - 10.1101/2020.12.11.20209627
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.12.11.20209627
4099  - http://medrxiv.org/content/early/2020/12/14/2020.12.11.20209627.short
4100  - http://medrxiv.org/content/early/2020/12/14/2020.12.11.20209627.full
AB  - Background Health disparities have emerged with the COVID-19 epidemic because the risk of exposure to infection and the prevalence of risk factors for severe outcomes given infection vary within and between populations. However, estimated epidemic quantities such as rates of severe illness and death, the case fatality rate (CFR), and infection fatality rate (IFR), are often expressed in terms of aggregated population-level estimates due to the lack of epidemiological data at the refined subpopulation level. For public health policy makers to better address the pandemic, stratified estimates are necessary to investigate the potential outcomes of policy scenarios targeting specific subpopulations.Methods We develop a framework for using available data on the prevalence of COVID-19 risk factors (age, comorbidities, BMI, smoking status) in subpopulations, and epidemic dynamics at the population level and stratified by age, to estimate subpopulation-stratified probabilities of severe illness and the CFR (as deaths over observed infections) and IFR (as deaths over estimated total infections) across risk profiles representing all combinations of risk factors including age, comorbidities, obesity class, and smoking status. A dynamic epidemic model is integrated with a relative risk model to produce time-varying subpopulation-stratified estimates. The integrated model is used to analyze dynamic outcomes and parameters by population and subpopulation, and to simulate alternate policy scenarios that protect specific at-risk subpopulations or modify the population-wide transmission rate. The model is calibrated to data from the Los Angeles County population during the period March 1 - October 15 2020.Findings We estimate a rate of 0.23 (95% CI: 0.13,0.33) of infections observed before April 15, which increased over the epidemic course to 0.41 (0.11,0.69). Overall population-average IFR(t) estimates for LAC peaked at 0.77% (0.38%,1.15%) on May 15 and decreased to 0.55% (0.24%,0.90%) by October 15. The population-average IFR(t) stratified by age group varied extensively across subprofiles representing each combination of the additional risk factors considered (comorbidities, BMI, smoking). We found median IFRs ranging from 0.009%-0.04% in the youngest age group (0-19), from 0.1%-1.8% for those aged 20-44, 0.36%-4.3% for those aged 45-64, and 1.02%-5.42% for those aged 65+. In the group aged 65+ for which the rate of unobserved infections is likely much lower, we find median CFRs in the range 4.4%-23.45%. The initial societal lockdown period avoided overwhelming healthcare capacity and greatly reduced the observed death count. In comparative scenario analysis, alternative policies in which the population-wide transmission rate is reduced to a moderate and sustainable level of non-pharmaceutical interventions (NPIs) would not have been sufficient to avoid overwhelming healthcare capacity, and additionally would have exceeded the observed death count. Combining the moderate NPI policy with stringent protection of the at-risk subpopulation of individuals 65+ would have resulted in a death count similar to observed levels, but hospital counts would have approached capacity limits.Interpretation The risk of severe illness and death of COVID-19 varies tremendously across subpopulations and over time, suggesting that it is inappropriate to summarize epidemiological parameters for the entire population and epidemic time period. This includes variation not only across age groups, but also within age categories combined with other risk factors analyzed in this study (comorbidities, obesity status, smoking). In the policy analysis accounting for differences in IFR across risk groups in comparing the control of infections and protection of higher risk groups, we find that the strict initial lockdown period in LAC was effective because it both reduced overall transmission and protected individuals at greater risk, resulting in preventing both healthcare overload and deaths. While similar numbers of deaths as observed in LAC could have been achieved with a more moderate NPI policy combined with greater protection of individuals 65+, this would have come at the expense of overwhelming the healthcare system. In anticipation of a continued rise in cases in LAC this winter, policy makers need to consider the trade offs of various policy options on the numbers of the overall population that may become infected, severely ill, and that die when considering policies targeted at subpopulations at greatest risk of transmitting infection and at greatest risk for developing severe outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementALH was supported from an NIH Ruth L Kirschstein National Research Service Award (NRSA) Institutional Training Grant T32 5T32CA00949235. DVC was supported by NIH P01CA196569 and NCI P30CA014089. EH was supported by NIH P01CA196569. DVC and ALH are also funded by COVID-19 Keck Research Fund from the University of Southern California.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data used in the study are aggregated counts at the level of Los Angeles County (a population of over 10 million). These data are openly available to the public without application or screening for access, and have been since the conception of our research study. Specifically, the data used in this study combines the data available on the dashboards from the public health departments of Los Angeles County (LAC) (http://dashboard.publichealth.lacounty.gov/covid19_surveillance_dashboard/), Long Beach (http://www.longbeach.gov/health/diseases-and-condition/information-on/coronavirus/), and Pasadena (https://www.cityofpasadena.net/covid-19/#dashboard). Co-authors on this paper who are employees of the Los Angeles County Department of Public Health combined the data input to these three resources, which they shared for use in this study. In addition, as noted in the Data Availability section, the data we used can be found in an open GitHub repository at the specific link: https://github.com/AbigailHorn/COV2-LA/tree/master/data All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and code required to reproduce the analysis in this manuscript can be found in the GitHub repository at https://github.com/AbigailHorn/COV2-LA. Specifically, see the `data` folder for all datasets used in our analysis. Additionally, interactive versions of some of the figures and tables provided in our analysis are provided on the repository website found at https://abigailhorn.github.io/COV2-LA. https://github.com/AbigailHorn/COV2-LA